Vilacto Bio Inc VIBI
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Vilacto Bio Inc is a biotech company. It operates a fully patented Lactoactive molecule for treating conditions such as inflammatory diseases, diabetics, psoriasis, and skin issues in different levels. The company is also intended to develop Lactoactive molecule for increasing the quality of its retail and medical skin cream product as well as developing products for medical applications. Its product portfolio includes lotions, skin care creams and gels, lip balms, foot creams and oils, and others.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- —
- Total Number of Employees
- 3
- Website
- https://www.vilacto.com
Valuation
|
Metric
|
VIBI
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
VIBI
|
|---|---|
Quick Ratio | 0.04 |
Current Ratio | 0.08 |
Interest Coverage | −4.75 |
Quick Ratio
VIBI
Profitability
|
Metric
|
VIBI
|
|---|---|
Return on Assets (Normalized) | −1,504.82% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
VIBI
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Vzttyngzh | Vtsmv | $557.8 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Dgdrtmsk | Chqlwt | $103.3 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Lvkptqx | Wmvppb | $98.8 Bil | |
MRNA
| Moderna Inc | Pjtzwhtf | Jbfk | $38.8 Bil | |
ARGX
| argenx SE ADR | Tfdbxrjvx | Rqbs | $21.3 Bil | |
BNTX
| BioNTech SE ADR | Nsbpljw | Lhyw | $20.8 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Lysgrcdw | Zfrznp | $18.4 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Wmnvgzqz | Sbmdwx | $17.0 Bil | |
RPRX
| Royalty Pharma PLC Class A | Hcrykcdb | Wmbkgqm | $12.4 Bil | |
INCY
| Incyte Corp | Xgstsztt | Zhqxtvh | $11.9 Bil |